Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M83,674Revenue (TTM) $M10,163Net Margin (%)19.0Altman Z-Score4.0
Enterprise Value $M91,582EPS (TTM) $2.4Operating Margin %27.6Piotroski F-Score7
P/E(ttm)45.4Beneish M-Score-2.4Pre-tax Margin (%)23.1Higher ROA y-yN
Price/Book15.110-y EBITDA Growth Rate %--Quick Ratio4.4Cash flow > EarningsY
Price/Sales8.65-y EBITDA Growth Rate %19.3Current Ratio4.6Lower Leverage y-yN
Price/Free Cash Flow29.5y-y EBITDA Growth Rate %7.9ROA % (ttm)7.7Higher Current Ratio y-yY
Dividend Yield %--PEG2.4ROE % (ttm)34.1Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M775ROIC % (ttm)19.8Gross Margin Increase y-yY

Gurus Latest Trades with CELG

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
CELGJulian Robertson 2016-06-30 Add4.78%$94.85 - $110.57
($103.39)
$ 107.954%Add 65.68%379,140
CELGRonald Muhlenkamp 2016-06-30 Buy 0.76%$94.85 - $110.57
($103.39)
$ 107.954%New holding19,809
CELGJoel Greenblatt 2016-06-30 Add0.3%$94.85 - $110.57
($103.39)
$ 107.954%Add 360.37%317,274
CELGKen Heebner 2016-06-30 Buy 0.09%$94.85 - $110.57
($103.39)
$ 107.954%New holding20,000
CELGKen Fisher 2016-06-30 Add$94.85 - $110.57
($103.39)
$ 107.954%Add 3.01%204,128
CELGMario Gabelli 2016-06-30 Reduce$94.85 - $110.57
($103.39)
$ 107.954%Reduce -0.57%26,988
CELGJulian Robertson 2016-03-31 Buy 5.74%$96.69 - $119.76
($103.22)
$ 107.955%New holding228,840
CELGJoel Greenblatt 2016-03-31 Buy 0.08%$96.69 - $119.76
($103.22)
$ 107.955%New holding68,917
CELGKen Fisher 2016-03-31 Reduce-0.01%$96.69 - $119.76
($103.22)
$ 107.955%Reduce -19.27%198,160
CELGMario Gabelli 2016-03-31 Reduce$96.69 - $119.76
($103.22)
$ 107.955%Reduce -7.26%27,144
CELGJoel Greenblatt 2015-12-31 Sold Out -0.01%$106.55 - $127.2
($115.78)
$ 107.95-7%Sold Out0
CELGMario Gabelli 2015-12-31 Reduce$106.55 - $127.2
($115.78)
$ 107.95-7%Reduce -0.19%29,270
CELGKen Fisher 2015-12-31 Add$106.55 - $127.2
($115.74)
$ 107.95-7%Add 0.37%245,460
CELGKen Heebner 2015-09-30 Sold Out -0.36%$104.79 - $139.01
($124.1)
$ 107.95-13%Sold Out0
CELGMario Gabelli 2015-09-30 Add$104.79 - $139.01
($124.1)
$ 107.95-13%Add 20.85%29,325
CELGKen Fisher 2015-09-30 Add$104.79 - $139.01
($124.1)
$ 107.95-13%Add 8.99%244,564
CELGJoel Greenblatt 2015-09-30 Reduce$104.79 - $139.01
($124.1)
$ 107.95-13%Reduce -18.44%6,344
CELGRonald Muhlenkamp 2015-06-30 Sold Out -2.08%$107.54 - $120.34
($114.34)
$ 107.95-6%Sold Out0
CELGKen Heebner 2015-06-30 Buy 0.36%$107.54 - $120.34
($114.34)
$ 107.95-6%New holding110,000
CELGJoel Greenblatt 2015-06-30 Reduce-0.01%$107.54 - $120.34
($114.34)
$ 107.95-6%Reduce -56.76%7,778
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

CELG is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


CELG: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LOUGHLIN JAMES JDirector 2016-08-23Sell27,500$114.1-5.39view
CASEY MICHAEL DDirector 2016-08-22Sell43,134$114.01-5.32view
HUGIN ROBERT Jsee remarks 2016-07-28Sell100,000$110-1.86view
HUGIN ROBERT Jsee remarks 2016-06-20Sell75,000$100.167.78view
KAPLAN GILLADirector 2016-04-04Sell15,967$101.846view
BONNEY MICHAEL WDirector 2016-03-03Buy2,000$103.014.8view
LOUGHLIN JAMES JDirector 2016-02-22Sell2,100$104.123.68view
MARIO ERNESTDirector 2015-12-28Sell40,000$119.36-9.56view
CASEY MICHAEL DDirector 2015-12-23Sell20,000$122.11-11.6view
KAPLAN GILLADirector 2015-12-21Sell14,464$110.62-2.41view

Press Releases about CELG :

Quarterly/Annual Reports about CELG:

News about CELG:

Articles On GuruFocus.com
Celgene: Is It a Buy? Jun 21 2016 
5 Attractive Biotechnology Stocks for Healthy Long-term Returns Jun 10 2016 
Gilead and Celgene Among Biotechnology Stocks to Buy May 26 2016 
DISH Network, H&R Block, Celgene, Plum Creek Timber Log Largest Insider Sells Jan 04 2016 
Taking a Look at Barron’s 10 Favorite Stocks for 2016 Dec 07 2015 
Celgene: A Primer on Growth Stock Value Investing - Part 2 Nov 13 2015 
My Top 3 Pharma Stock Picks Jun 09 2015 
10 Reasons Why Growth Stocks Can Be Appropriate for Retired Investors Jun 04 2015 
Big Pharma Companies Are Betting On Regenerative Medicine - Should You? May 26 2015 
Celgene’s Earnings Shine While Revenue Misses By An Inch In The First Quarter May 06 2015 

More From Other Websites
Celgene Corporation to Webcast at Upcoming Investor Conferences and R&D Deep Dive in September Aug 29 2016
Celgene Corporation to Webcast at Upcoming Investor Conferences and R&D Deep Dive in September Aug 29 2016
What Do Analysts Think about BioMarin’s Return Potential? Aug 26 2016
Biotech Stocks: Oops, She Did It Again Aug 25 2016
Short Sellers Increase Bets in Major Biotechs Aug 25 2016
Mylan price hike happy? Aug 23 2016
What Are Analysts’ Recommendations for AbbVie in 2016? Aug 23 2016
[$$] Pfizer’s Medivation Deal Latest in Long Line of Similar Acquisitions Aug 22 2016
Medivation Scores Premium in Sale to Pfizer Aug 22 2016
[$$] Pfizer's Medivation Deal Latest in Long Line of Similar Acquisitions Aug 22 2016
ETF’s with exposure to Celgene Corp. : August 22, 2016 Aug 22 2016
Pfizer buys Medivation $14 billion cash Aug 22 2016
From Nightmare Drug to Celgene Blockbuster, Thalidomide Is Back Aug 22 2016
Biotech Stocks: Trouble Ahead, Trouble Behind? Aug 19 2016
CELG Expects This Investigational Drug to Be a Key Growth Driver Aug 19 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)